Michael E Rome - Net Worth and Insider Trading

Michael E Rome Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael E Rome owns 5 companies in total, including FS Development Corp (FSDC) , Theseus Pharmaceuticals Inc (THRX) , and Kinnate Biopharma Inc (KNTE) among others .

Click here to see the complete history of Michael E Rome’s form 4 insider trades.

Insider Ownership Summary of Michael E Rome

Ticker	Comapny	Transaction Date	Type of Owner
FSDC	FS Development Corp	2020-08-11	director & Vice President
THRX	Theseus Pharmaceuticals Inc	2021-10-06	director
KNTE	Kinnate Biopharma Inc	2020-12-02	director
		2020-08-11	director & Vice President
		2021-02-16	director & Vice President

Michael E Rome Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael E Rome Ownership Network

Ownership Network List of Michael E Rome

No Data

Ownership Network Relation of Michael E Rome

Michael E Rome Owned Company Details

What does FS Development Corp do?

Who are the key executives at FS Development Corp?

Michael E Rome is the director & Vice President of FS Development Corp. Other key executives at FS Development Corp include director & 10 percent owner & President & CEO James B. Tananbaum , 10 percent owner Foresite Capital Fund V, L.p. , and 10 percent owner Foresite Capital Management V, Llc .

FS Development Corp (FSDC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of FS Development Corp (FSDC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of FS Development Corp (FSDC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

FS Development Corp (FSDC)'s detailed insider trading history can be found in Insider Trading Tracker table.

FS Development Corp Insider Transactions

No Available Data

What does Theseus Pharmaceuticals Inc do?

Who are the key executives at Theseus Pharmaceuticals Inc?

Michael E Rome is the director of Theseus Pharmaceuticals Inc. Other key executives at Theseus Pharmaceuticals Inc include director & 10 percent owner Carl L Gordon , director & 10 percent owner Orbimed Advisors Llc , and 10 percent owner Foresite Capital Fund V, L.p. .

Theseus Pharmaceuticals Inc (THRX) Insider Trades Summary

Over the past 18 months, Michael E Rome made no insider transaction in Theseus Pharmaceuticals Inc (THRX). Other recent insider transactions involving Theseus Pharmaceuticals Inc (THRX) include a net purchase of 700,000 shares made by Foresite Capital Fund V, L.p. , a net purchase of 479,932 shares made by Orbimed Advisors Llc , and a net purchase of 479,932 shares made by Carl L Gordon .

In summary, during the past 3 months, insiders sold 0 shares of Theseus Pharmaceuticals Inc (THRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Theseus Pharmaceuticals Inc (THRX) were sold and 1,659,864 shares were bought by its insiders, resulting in a net purchase of 1,659,864 shares.

Theseus Pharmaceuticals Inc (THRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Theseus Pharmaceuticals Inc Insider Transactions

No Available Data

What does Kinnate Biopharma Inc do?

Who are the key executives at Kinnate Biopharma Inc?

Michael E Rome is the director of Kinnate Biopharma Inc. Other key executives at Kinnate Biopharma Inc include director & 10 percent owner James B. Tananbaum , 10 percent owner Foresite Capital Fund Iv, L.p. , and director & 10 percent owner Orbimed Capital Gp Viii Llc .

Kinnate Biopharma Inc (KNTE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Kinnate Biopharma Inc (KNTE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kinnate Biopharma Inc (KNTE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kinnate Biopharma Inc (KNTE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kinnate Biopharma Inc Insider Transactions

No Available Data

What does Disc Medicine Inc do?

Who are the key executives at Disc Medicine Inc?

Michael E Rome is the director & Vice President of Disc Medicine Inc. Other key executives at Disc Medicine Inc include Chief Medical Officer William Jacob Savage , director & 10 percent owner Orbimed Advisors Llc , and director & 10 percent owner Mona Ashiya .

Disc Medicine Inc (IRON) Insider Trades Summary

Over the past 18 months, Michael E Rome made no insider transaction in Disc Medicine Inc (IRON). Other recent insider transactions involving Disc Medicine Inc (IRON) include a net sale of 48,126 shares made by William Richard White , a net sale of 75,429 shares made by Kevin Bitterman , and a net sale of 1,106,612 shares made by Atlas Venture Fund X, L.p. .

In summary, during the past 3 months, insiders sold 12,495 shares of Disc Medicine Inc (IRON) in total and bought 0 shares, with a net sale of 12,495 shares. During the past 18 months, 3,914,721 shares of Disc Medicine Inc (IRON) were sold and 388,891 shares were bought by its insiders, resulting in a net sale of 3,525,830 shares.

Disc Medicine Inc (IRON)'s detailed insider trading history can be found in Insider Trading Tracker table.

Disc Medicine Inc Insider Transactions

No Available Data

What does Pardes Biosciences Inc do?

Who are the key executives at Pardes Biosciences Inc?

Michael E Rome is the director & Vice President of Pardes Biosciences Inc. Other key executives at Pardes Biosciences Inc include 10 percent owner Fs Development Holdings Ii, Llc , 10 percent owner Foresite Capital Fund V, L.p. , and 10 percent owner Foresite Capital Opportunity Fund V, L.p. .

Pardes Biosciences Inc (PRDS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Pardes Biosciences Inc (PRDS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pardes Biosciences Inc (PRDS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pardes Biosciences Inc (PRDS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pardes Biosciences Inc Insider Transactions

No Available Data

Michael E Rome Mailing Address

Above is the net worth, insider trading, and ownership report for Michael E Rome. You might contact Michael E Rome via mailing address: 600 Montgomery Street, Suite 4500, San Francisco Ca 94111.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.